This past year presented so many different challenges and obstacles that tested our strength and resiliency. The global pandemic forced
read full article ›Here we go again… on May 3rd Cvshealth released the CVS Caremark 2020 Drug Trend Report. One eye-catching stat was the
read full article ›The FDA’s accelerated approval process drives tremendous upside benefits for manufactures and patients through delivery of therapeutic innovations earlier than
read full article ›